1. 3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS). (September 2015) Authors: Patel, S.; Mehren, M. Von; Reed, D.; Agulnik, M.; Kaiser, P.; Charlson, J.; Kraft, A.; Hamm, J.; Karnad, A.; Ryan, C.; Rushing, D.; Meyer, C.; Khokhar, N.Z.; McCarthy, S.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Demetri, G.D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Feasibility of bilingual self-CGA using REDCap in patients with hepatocellular carcinoma (HCC) at a Latinx-rich U.S. Cancer Center. (October 2022) Authors: Arora, S.; Girard, V.; Arellano, L.; Salazar, M.; Diaz, E.; Joel, M.; Karnad, A. Journal: Journal of geriatric oncology Issue: Volume 13(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pilot observational study of patients with liver cancer receiving first-line treatment: preliminary data on ADLs, IADLs, and Timed Up and Go (TUG). (December 2021) Authors: Kapoor, V.; Janania Martinez, M.; Alvarez, G.; Michalek, J.; Karnad, A.; Arora, S. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗